{"nct_id":"NCT04172675","title":"A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2020-02-28","start_date_type":"ACTUAL","primary_completion_date":"2024-07-12","primary_completion_date_type":"ACTUAL","completion_date":"2025-02-27","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["JNJ"]}